Clara Patricia Setton-Avruj

Dr. Clara Patricia Setton-Avruj


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Acta Biomaterialia
Verified
Journal Article
Closed access
PSPaula A. Soto
Paula A. Soto
MVMarianela Vence
Marianela Vence
GPGonzalo M. Piñero
Gonzalo M. Piñero
DCDiego Coral
Diego Coral
VUVanina Usach
Vanina Usach
CSClara Patricia Setton-Avruj
Clara Patricia Setton-Avruj

19 October 2018 in Nanoscale
Verified
Journal Article
Closed access
PDF file
DCDiego Coral
Diego Coral
PSP. A. Soto
P. A. Soto
VBV. Blank
V. Blank
AVA. Veiga
A. Veiga
ESEnrique Mario Spinelli
Enrique Mario Spinelli
MRM. B. Fernández van Raap
M. B. Fernández van Raap
Magnetic hyperthermia is an oncological therapy where magnetic nanostructures, under a radiofrequency field, act as heat transducers increasing tumour temperature and killing cancerous cells. Nanostructure heating efficiency depends both on the field conditions and on the nanostructure properties and mobility inside the tumour. Such nanostructures are often incorrectly bench-marketed in the colloidal state and using field settings far off from the recommended therapeutic values. Here, we prepared nanoclusters composed of iron oxide magnetite nanoparticles crystallographically aligned and their specific absorption rate (SAR) values were calorimetrically determined in physiological fluids, agarose-gel-phantoms and ex vivo tumours extracted from mice challenged with B16-F0 melanoma cells. A portable, multipurpose applicator using medical field settings; 100 kHz and 9.3 kA m−1, was developed and the results were fully analysed in terms of nanoclusters’ structural and magnetic properties. A careful evaluation of the nanoclusters’ heating capacity in the three milieus clearly indicates that the SAR values of fluid suspensions or agarose-gel-phantoms are not adequate to predict the real tissue temperature increase or the dosage needed to heat a tumour. Our results show that besides nanostructure mobility, perfusion and local thermoregulation, the nanostructure distribution inside the tumour plays a key role in effective heating. A suppression of the magnetic material effective heating efficiency appears in tumour tissue. In fact, dosage had to be increased considerably, from the SAR values predicted from fluid or agarose, to achieve the desired temperature increase. These results represent an important contribution towards the design of more efficient nanostructures and towards the clinical translation of hyperthermia.

28 April 2011 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
VUVanina Usach
Vanina Usach
BGBelén Goitia
Belén Goitia
LLLucía Lavalle
Lucía Lavalle
RVRocío Martinez Vivot
Rocío Martinez Vivot
CSClara Patricia Setton-Avruj
Clara Patricia Setton-Avruj

16 February 2018 in Transgenic Research
Verified
Journal Article
Open access
PDF file
GPGonzalo Piñero
Gonzalo Piñero
VUVanina Usach
Vanina Usach
PSPaula A. Soto
Paula A. Soto
Paula V. MonjePaula V. Monje
Paula V. Monje
CSClara Patricia Setton-Avruj
Clara Patricia Setton-Avruj
Bone marrow mononuclear cells (BMMC) constitute a heterogeneous population with potential to promote tissue regeneration. For this reason, this cell fraction has recently become a therapeutic alternative to mesenchymal stem cells, as culture is not required and phenotypic transformations can be hence avoided. In this work, and in order to attain long-lasting cell labeling and study longer survival times, we used BMMC isolated from adult transgenic rats expressing GFP to reproduce our wild type model and evaluate their remyelination ability in a reversible model of Wallerian degeneration. RT-PCR and flow cytometry analysis confirmed that cells isolated from the transgenic strain exhibited similar expression levels of markers specific to multipotent progenitors (CD34, CD90 and CD105) and Schwann cells (MPZ, MBP, S100β and p75NTR) compared to wild type BMMC. BMMC expressing GFP retained their migration capacity, arriving exclusively at the injured nerve. Most importantly, and as detected through long-lasting cell tracking, some of these BMMC settled in the demyelinated area, mingled with endogenous cells, underwent phenotypic changes and colocalized with Schwann cell markers MBP and S100β. Also worth highlighting, transgenic BMMC replicated wild type BMMC effects in terms of MBP organization and levels. On the basis of these findings, BMMC isolated from transgenic animals constitute a useful tool to evaluate their role in peripheral nervous system demyelination-remyelination and the underlying mechanisms.

30 January 2013 in BioFactors
Verified
Journal Article
Closed access
PDF file
RVRocio Martínez Vivot
Rocio Martínez Vivot
BGBelén Goitia
Belén Goitia
VUVanina Usach
Vanina Usach
CSClara Patricia Setton-Avruj
Clara Patricia Setton-Avruj

1 July 2017 in Transplantation
Verified
Journal Article
Open access
VUVanina Usach
Vanina Usach
MMMariana Malet
Mariana Malet
MLMargarita López
Margarita López
LLLucía Lavalle
Lucía Lavalle
GPGonzalo Piñero
Gonzalo Piñero
CSClara Patricia Setton-Avruj
Clara Patricia Setton-Avruj
Background Reinnervation timing after nerve injury is critical for favorable axonal regeneration, remyelination, and clinical improvement. Considering bone marrow mononuclear cells (BMMC) are easily obtained and readily available for transplant, this work analyzed the effect of BMMC systemic administration on nerve repair and pain behavior. Methods Adult rats with sciatic nerve crush were immediately and systemically injected BMMC through the caudal artery. Nontreated, sham and naïve rats were also included. Histological, immunohistochemical, biochemical, functional, and behavioral analyses were performed in nerves harvested from each group at different survival times. Results Axons in BMMC-treated rats exhibited a more conserved morphological appearance than those in nontreated rats, as observed at different survival times both in semithin sections and ultrastructural analysis. BMMC-treated rats also showed a reduction in major myelin protein immunoreactive clusters 7 and 14 days postinjury, as compared with nontreated rats. Electrophysiological analysis showed BMMC treatment to slightly improve the amplitude of compound muscle action potential starting at 14 days postinjury. Finally, mechanical withdrawal threshold revealed a full preventive action against transient mechanical hypersensitivity in BMMC-treated rats. Conclusions These data demonstrate the efficiency of BMMC, systemically and noninvasively transplanted, in correcting morphological, functional and behavioral alterations resulting from peripheral nerve injury.